NCT00004409 2015-03-25
Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease
FDA Office of Orphan Products Development
Phase 2 Completed
FDA Office of Orphan Products Development
FDA Office of Orphan Products Development